Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include creamer and chocolate systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, ice cream bases and variegates, cereals, grain based snacks, and cereal based ingredients. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. Its Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The company's Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. It also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company's Industrial Products segment provides choline chloride derivatives for hydraulic fracturing of shale natural gas wells; and methylamines, which are building blocks for the manufacture of choline products, as well as used in industrial applications. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was founded in 1967 and is headquartered in New Hampton, New York.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
SymbolNASDAQ:BCPC
CUSIP05766520
Phone845-326-5600
Debt
Debt-to-Equity Ratio0.33
Current Ratio3.98
Quick Ratio2.82
Price-To-Earnings
Trailing P/E Ratio42.83
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$594.79 million
Price / Sales6.23
Cash Flow$3.9013 per share
Price / Cash29.47
Book Value$19.27 per share
Price / Book5.97
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$90.07 million
Net Margins15.28%
Return on Equity13.78%
Return on Assets8.90%
Miscellaneous
Employees1,165
Outstanding Shares32,210,000
Market Cap$3.74 billion
Balchem (NASDAQ:BCPC) Frequently Asked Questions
What is Balchem's stock symbol?
Balchem trades on the NASDAQ under the ticker symbol "BCPC."
How often does Balchem pay dividends? What is the dividend yield for Balchem?
Balchem declared an annual dividend on Wednesday, December 13th. Shareholders of record on Wednesday, December 27th will be paid a dividend of $0.42 per share on Friday, January 19th. This represents a yield of 0.5%. The ex-dividend date is Tuesday, December 26th. This is a positive change from Balchem's previous annual dividend of $0.38. View Balchem's Dividend History.
How were Balchem's earnings last quarter?
Balchem Co. (NASDAQ:BCPC) issued its earnings results on Friday, August, 3rd. The basic materials company reported $0.76 EPS for the quarter, topping the consensus estimate of $0.75 by $0.01. The basic materials company had revenue of $163.70 million for the quarter, compared to analyst estimates of $163.20 million. Balchem had a return on equity of 13.78% and a net margin of 15.28%. Balchem's revenue for the quarter was up 11.3% on a year-over-year basis. View Balchem's Earnings History.
When is Balchem's next earnings date?
What price target have analysts set for BCPC?
2 brokerages have issued 1 year price objectives for Balchem's shares. Their forecasts range from $95.00 to $95.00. On average, they anticipate Balchem's stock price to reach $95.00 in the next twelve months. This suggests that the stock has a possible downside of 17.4%. View Analyst Price Targets for Balchem.
What is the consensus analysts' recommendation for Balchem?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Balchem.
Who are some of Balchem's key competitors?
Some companies that are related to Balchem include FMC (FMC), Johnson Matthey (JMPLY), Chemours (CC), Huntsman (HUN), Ashland Global (ASH), KURARAY Co Ltd/ADR (KURRY), W. R. Grace & Co (GRA), Olin (OLN), Ingevity (NGVT), Univar (UNVR), PQ Group (PQG), GCP Applied Technologies (GCP), Innospec (IOSP), KMG Chemicals (KMG) and Nexeo Solutions (NXEO).
Who are Balchem's key executives?
Balchem's management team includes the folowing people:
- Mr. Theodore L. Harris, Chairman and Chief Exec. Officer (Age 53)
- Ms. Mary Theresa Coelho, Chief Financial Officer and Treasurer (Age 56)
- Mr. William A. Backus CPA, Chief Accounting Officer (Age 52)
- Mr. Mark A. Stach, Gen. Counsel & Corp. Sec.
- Mr. David F. Ludwig, VP & Gen. Mang. of Industrial Products (Age 60)
Who are Balchem's major shareholders?
Balchem's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (13.67%), Wasatch Advisors Inc. (2.59%), Dimensional Fund Advisors LP (2.27%), Conestoga Capital Advisors LLC (2.03%), Northern Trust Corp (1.42%) and Janus Henderson Group PLC (1.29%). Company insiders that own Balchem stock include Dino A Rossi, Edward Mcmillan and William A Backus. View Institutional Ownership Trends for Balchem.
Which major investors are selling Balchem stock?
BCPC stock was sold by a variety of institutional investors in the last quarter, including Summit Creek Advisors LLC, Cortina Asset Management LLC, Macquarie Group Ltd., Russell Investments Group Ltd., Renaissance Technologies LLC, Strs Ohio, PNC Financial Services Group Inc. and Royce & Associates LP. View Insider Buying and Selling for Balchem.
Which major investors are buying Balchem stock?
BCPC stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Conestoga Capital Advisors LLC, Janus Henderson Group PLC, Virginia Retirement Systems ET AL, Tributary Capital Management LLC, Bank of America Corp DE, Stephens Investment Management Group LLC and Fred Alger Management Inc.. View Insider Buying and Selling for Balchem.
How do I buy shares of Balchem?
Shares of BCPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Balchem's stock price today?
One share of BCPC stock can currently be purchased for approximately $114.97.
How big of a company is Balchem?
Balchem has a market capitalization of $3.74 billion and generates $594.79 million in revenue each year. Balchem employs 1,165 workers across the globe.
What is Balchem's official website?
How can I contact Balchem?
Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The basic materials company can be reached via phone at 845-326-5600 or via email at [email protected]
MarketBeat Community Rating for Balchem (NASDAQ BCPC)
MarketBeat's community ratings are surveys of what our community members think about Balchem and other stocks. Vote "Outperform" if you believe BCPC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BCPC will underperform the S&P 500 over the long term. You may vote once every thirty days.
